ClinVar Miner

Submissions for variant NM_144997.7(FLCN):c.927_954dup (p.Gly319fs) (rs398124542)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics,Children's Hospital of Philadelphia RCV000239656 SCV000298065 pathogenic Multiple fibrofolliculomas 2016-07-18 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000082645 SCV000331101 pathogenic not provided 2015-07-10 criteria provided, single submitter clinical testing
GeneDx RCV000082645 SCV000565007 pathogenic not provided 2021-04-16 criteria provided, single submitter clinical testing Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek 2016); This variant is associated with the following publications: (PMID: 23757202, 12204536, 11836379, 15852235, 18234728, 19802896, 19788617, 26402642, 21937013, 19562744)
Ambry Genetics RCV000492117 SCV000580733 pathogenic Hereditary cancer-predisposing syndrome 2016-03-10 criteria provided, single submitter clinical testing <span style="font-family:arial,sans-serif; font-size:10pt">The<span style="font-family:arial,sans-serif">c.927_<span style="font-family:arial,sans-serif; font-size:10pt">954dup28<span style="font-family:arial,sans-serif; font-size:10pt"><span style="font-family:arial,sans-serif; font-size:10pt">pathogenic mutation, located in codingexon6 of the<span style="font-family:arial,sans-serif; font-size:10pt">FLCN<span style="font-family:arial,sans-serif; font-size:10pt"><span style="font-family:arial,sans-serif; font-size:10pt">gene, results from a duplication of 28 nucleotides between positions 927 and 954 causing a translationalframeshiftwith a predicted alternate stopcodon. This alteration has been reported as a recurrent mutation in families clinically diagnosed with Birt-Hogg-Dub&eacute; syndrome (Schmidt LS et al.Abstract O-27.<span style="font-family:arial,sans-serif">Fam. Cancer2011 May; 10Suppl3:S103-16). This mutation was also reported in a 56 year old man with multiple fibrofolliculomas (Wang J et al. Genet. Med. 2015 Sep [epub ahead of print]). Inaddition to the clinical data presented in the literature, sinceframeshiftsare typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMGRecommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007.<span style="font-family:arial,sans-serif">Genet Med. 2008;10:294).
Invitae RCV000239656 SCV000756986 pathogenic Multiple fibrofolliculomas 2020-07-15 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gly319Serfs*80) in the FLCN gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported to segregate with Birt-Hogg-Dubé (BHD) syndrome in a single family. It has also been observed in unrelated individuals with BHD (PMID: 12204536, 19802896), and an individual with multiple fibrofolliculomas (PMID: 26402642). This variant is also known as c.923_950dup and 1378-1405dup in the literature. ClinVar contains an entry for this variant (Variation ID: 96493). Loss-of-function variants in FLCN are known to be pathogenic (PMID: 15852235). For these reasons, this variant has been classified as Pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000781384 SCV000919363 pathogenic Pneumothorax, primary spontaneous 2018-03-16 criteria provided, single submitter clinical testing Variant summary: FLCN c.927_954dup28 (p.Gly319SerfsX80) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. A truncation downstream of this position, c.1389C>G (p.Tyr463X) has been classified as pathogenic by our laboratory. The variant was absent in 121372 control chromosomes (ExAC). The variant, c.927_954dup28, also known as c.1378_1405dup, has been reported in the literature in multiple individuals affected with Birt-Hogg-Dube Syndrome (Schmidt_2005). These data indicate that the variant is very likely to be associated with disease. Co-occurrence with another pathogenic variant has been reported (PMS2 c.2186_2187delTC, p.Leu729fsX6). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Multiple ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cites the variant as "pathogenic." Based on the evidence outlined above, the variant was classified as pathogenic.
OMIM RCV000239656 SCV000023691 pathogenic Multiple fibrofolliculomas 2009-09-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.